Association of CD 34 positive cell dose with engraftment kinetics in autologous peripheral blood stem cell transplant patients of multiple myeloma.

Kushwaha, Neerja; Kumar, Sudeep; Sheikh, Mohd Anas; Philip, Joseph; Sharma, Sanjeevan; Biswas, Amit Kumar; Joshi, Rajneesh Kumar

Kushwaha, Neerja; Kumar, Sudeep; Sheikh, Mohd Anas; Philip, Joseph; Sharma, Sanjeevan; Biswas, Amit Kumar; Joshi, Rajneesh Kumar.

Afiliação

Kushwaha N; Classified Specialist (Immunohematology & Blood Transfusion), Command Hospital (Central Command), Lucknow, India.
Kumar S; Classified Specialist (Immunohematology & Blood Transfusion), AFTC, Delhi Cantt, India.
Sheikh MA; Resident, Dept of Immunohematology & Blood Transfusion, Armed Forces Medical College, Pune 40, India.
Philip J; Professor & Head (Immunohematology & Transfusion Medicine), Bharati Vidyapeeth Medical College & Hospital, Pune 40, India.
Sharma S; Senior Advisor (Medicine & Clinical Hematology), Command Hospital (Central Command), Lucknow, India.
Biswas AK; Associate Professor, Dept of Immunohematology & Blood Transfusion, Armed Forces Medical College, Pune 40, India.
Joshi RK; ADH, HQ 15 Corps, C/o 56 APO.

Med J Armed Forces India ; 78(3): 296-301, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35855709

Palavras-chave

CD 34 cell dose; Engraftment; Multiple myeloma; PBSCT; Plerixafor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Med J Armed Forces India Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google